Popular Articles

Diagnostic Evaluation Of PSA Recurrence And Review Of Hormonal Management After Radical Prostatectomy
UroToday.com - At present, no consensus exists on how patients with PSA recurrence after radical prostatectomy (RP) should be treated. Although patients with postoperative PSA recurrence frequently undergo androgen deprivation therapy (ADT) before evidence of metastatic disease, the benefit of this approach is uncertain. As no randomized studies are performed in this clinical setting there is no conclusive evidence that hormone therapy (HT) after RP will prolong survival or reduce morbidity.

Medicare Expenditures Decrease For Glaucoma Surgery As Number Of Procedures Increases
The overall number of glaucoma surgical procedures appears to be increasing, but payments by Medicare for the procedures have been decreasing, according to a report in the July issue of Archives of Ophthalmology, one of the JAMA/Archives journals.
News of the day
Triple Drug Combination Is Promising Option To Treat Metastatic HER2+ Breast Cancer
Combining two chemotherapy drugs with trastuzumab (Herceptin) to treat women who have metastatic HER2+ breast cancer may offer physicians another choice in their treatment options.
Nutrition

Analysis Does Not Support Association Between Genetic Marker, Stress And Risk Of Depression

Contrary to a previous report, an analysis of 14 previous studies does not find an association between a serotonin transporter gene variation, stressful life events, and an increased risk of major depression, according to an article in the June 17 issue of JAMA. The authors did find that the number of stressful life events is associated with depression. Despite progress in risk gene identification for several complex diseases, few disorders have proven as resistant to gene identification as psychiatric illnesses. Although these disorders have long been assumed to result from some combination of genetic vulnerability and environmental exposure, direct evidence from a specific example has not been forthcoming. "Few if any of the genes identified in candidate gene association studies of psychiatric disorders have withstood the test of replication and to date, genome-wide association studies of psychiatric disorders have also had limited success," the authors write. One previous study (Caspi et al) concluded that, in interaction with stressful life events, genetic variation of the serotonin transporter gene (5-HTTLPR) plays a role in predisposition to major depression. Neil Risch, Ph.D., of the University of California at San Francisco and Kaiser Permanente Northern California Division of Research, Oakland, and colleagues conducted a meta-analysis of the interaction between the serotonin transporter gene and stressful life events on depression. The researchers identified 14 studies that met criteria for inclusion in the analysis. Of a total of 14,250 participants, 1,769 were classified as having depression; 12,481 as not having depression. The researchers found there was no association between 5-HTTLPR genotype and depression in any of the individual studies nor in the weighted average and no interaction effect between genotype and stressful life events on depression was observed. Comparable results were found in the sex-specific meta-analysis of individual-level data. The meta-analysis did show that the number of stressful life events was significantly associated with depression. The authors suggest that these results indicate why it is important that studies that find genetic associations be replicated. "A more serious concern ò€¦ is that the findings of this [Caspi et al] and other nonreplicated genetic associations are now being translated to a range of clinical, legal, research, and social settings such as forensics, diagnostic testing, study participants, and the general public. It is critical that health practitioners and scientists in other disciplines recognize the importance of replication of such findings before they can serve as valid indicators of disease risk or have utility for translation into clinical and public health practice." (JAMA. 2009;301[23]:2462-2471) American Medical Association (AMA)


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):